Determining Muscle's Force and Action in Multi‐Articular Movement

F. Zajac,M. Gordon

DOI: https://doi.org/10.1249/00003677-198900170-00009

1989-01-01

Exercise and Sport Sciences Reviews

Abstract:

What problem does this paper attempt to address?

Bi-functional astaxanthin macromolecular nanocarriers to alleviate dextran sodium sulfate-induced inflammatory bowel disease

Xiumin Zhang,Wentao Su,Yannan Chen,Shanghua Xing,A M Abd El-Aty,Yukun Song,Mingqian Tan

DOI: https://doi.org/10.1016/j.ijbiomac.2023.128494

Abstract:Dextran sulfate sodium is one of the important members in the field of polysaccharide biotechnology, which can induce inflammatory bowel disease (IBD) in the gastrointestinal tract. Nevertheless, the application of astaxanthin (AST) and epigallocatechin-3-gallate (EGCG), known for their pronounced antioxidant and anti-inflammatory properties, is encumbered by limited stability and bioavailability. To surmount this challenge, dual nutritional macromolecular nanoparticles were provided for alleviating IBD. The forementioned strategy entailed the utilization of EGCG as a wall material via the Mannich reaction, resulting in the creation of specialized nanocarriers capable of mitochondrial targeting and glutathione-responsive AST delivery. In vitro investigations, these nanocarriers demonstrated an enhanced propensity for mitochondrial accumulation, leading to proficient elimination of reactive oxygen species and preservation of optimal mitochondrial membrane potential about 1.5 times stronger than free AST and EGCG. Crucially, in vivo experiments showed that the colon length of IBD mice treated with these nanocarriers increased by 51.29 % and facilitated the polarization of M2 macrophages. Moreover, the assimilation of these nanocarriers exerted a favorable impact on the composition of gut microbiota. These findings underscore the immense potential of dual nutrition nanocarriers in contemporaneously delivering hydrophobic biological activators through oral absorption, thereby presenting a highly promising avenue for combating IBD.
Microenvironment responsive pod-structured astaxanthin nanocarrier for ameliorating inflammatory bowel disease

Jingting Wang,Yuanyuan Chen,Linlin Han,Shasha Xia,Xingyao Zhang,Peng Xue,Yuejun Kang,Jian Ming,Zhigang Xu

DOI: https://doi.org/10.1016/j.cclet.2023.109029

IF: 9.1

2023-09-05

Chinese Chemical Letters

Abstract:Anti-inflammatory drugs targeting inflammatory bowel disease (IBD) have attracted considerable attention but still face low therapeutic outcomes and frequent side effects. Astaxanthin (ATX), a natural ketone, possesses potent antioxidant and anti-inflammatory properties. However, it faces problems such as poor water solubility, photothermal instability, and low bioavailability. Here, we employed a supramolecular encapsulation strategy to create a nanoscale oral delivery system for ATX (referred to as FC-ATX NPs) by coupling fucoidan (FUC) with chitosan oligosaccharides (COS). The obtained FC-ATX NPs exhibited a particular "bean pod" structure with uniform size, good encapsulation efficiency, excellent physical and chemical stability, pH-triggered intestinal targeted slow-release properties, and potent antioxidant capacity. In vitro cell culture experiments showed that FC-ATX NPs promoted cellular uptake and scavenged excessive intracellular reactive oxygen species (ROS). In mouse models of colitis, FC-ATX NPs enhanced the drug absorption of intestinal epithelial cells and effectively accumulated at the site of inflammation. This work provides an efficient approach to enhance the bioavailability of ATX and has excellent application potential as an oral targeted delivery system for colitis therapy.

chemistry, multidisciplinary
Broad-Spectrum Reactive Oxygen Species Scavenging And Activated Macrophage-Targeting Microparticles Ameliorate Inflammatory Bowel Disease

Jiawei Li,Huiqiang Qiu,Hengtai Gong,Weijun Tong

DOI: https://doi.org/10.1021/acs.biomac.1c00551

2021-01-01

Biomacromolecules

Abstract:Inflammatory bowel disease (IBD) is a refractory chronic inflammatory disease. An excessively high level of reactive oxygen species (ROS) in the colon is one of the characteristics and pathogenic factors of IBD. Therefore, scavenging excessive ROS is a feasible method to treat IBD. Because ROS include many types of species, scavenging a single kind of ROS is not enough to reduce the ROS level and cure IBD effectively. Herein, broad-spectrum ROS scavenging and activated macrophage-targeting microparticles (MPs) are successfully fabricated by coprecipitation of catalase (CAT) and bovine serum albumin into a MnCO3 template followed by deposition of polydopamine (PDA), assembly of targeting molecules on the surface, and finally removal of MnCO3. The CAT content of MPs is about 34.1%. The obtained MPs can effectively scavenge the broad spectrum of ROS and retain 88% of the radical scavenging activity even after the treatment of simulated gastric fluid. The surface-modified dextran sulfate endows MPs with the targeting ability toward activated macrophages, achieving a better therapeutic effect. The MPs with components mostly derived from natural substances exhibit good biocompatibility and can show excellent ROS scavenging ability in cell experiments. In animal experiments, oral administration of a proper dosage of MPs can substantially mitigate colonic inflammation, as evidenced by disease activity index scores reduced by similar to 40%, reduced body weight loss, and the production of typical proinflammatory cytokines in the inflammatory colon. This kind of MP can also be utilized for the treatment of other inflammatory diseases.
Orally Administrated Inflamed Colon-Targeted Nanotherapeutics for Inflammatory Bowel Disease Treatment by Oxidative Stress Level Modulation in Colitis

Dong Kwang Min,Ye Eun Kim,Min Kyung Kim,Seung Woo Choi,Nuri Park,Jaeyun Kim

DOI: https://doi.org/10.1021/acsnano.3c11089

IF: 17.1

2023-12-12

ACS Nano

Abstract:Inflammatory bowel disease (IBD) is characterized by an inappropriate and persistent inflammatory immune response and is often accompanied by excessive reactive oxygen species (ROS) production. For effective IBD treatment, there is a high demand for safe and targeted therapy that can be orally administered. In this study, we aimed to propose the use of inflamed colon-targeted antioxidant nanotherapeutics (ICANs) for in situ oxidative stress level modulation in colitis. ICANs consist of mesoporous silica nanoparticles (MSNs) with surface-attached ROS-scavenging ceria nanoparticles (CeNPs), which are further coated with poly(acrylic acid) (PAA) to facilitate preferential adherence to inflamed colon tissues through electrostatic interaction. We achieved a high ROS-scavenging property that remained effective even after artificial gastrointestinal fluid incubation by optimization of the molecular weight and PAA-coating pH. The orally administered ICANs demonstrated enhanced adherence to inflamed colon tissues in an acute inflammation mouse model of IBD induced by dextran sulfate sodium. This targeted delivery resulted in gut microenvironment modulation by regulating redox balance and reducing inflammatory cell infiltration, thereby suppressing the colitis-associated immune response. These findings highlight the potential of noninvasive ICANs as a promising candidate for treating inflammatory intestinal diseases by oxidative stress level modulation in colitis.
Deoxyribonucleotide phosphatase from rat liver and cultured mouse fibroblasts.

G. Magnusson

DOI: https://doi.org/10.1111/J.1432-1033.1971.TB01384.X

1971-05-01

European Journal of Biochemistry

Abstract:An enzyme which catalyzes the preferential dephosphorylation of the 5′-phosphates of deoxythymidine, deoxyuridine and deoxyguanosine was purified 100-fold from rat liver. The preparation appeared to be free from contaminating phosphatase activities. The dephosphorylation of deoxyribonucleotides was dependent on the presence of Mg2+ ions and had a pH optimum around 6.0. The Km value for the dephosphorylation of deoxythymidine 5′-phosphate was 5.7 mM. High activities of the enzyme were found in cultured mouse fibroblasts. In parasynchronously growing cells no changes of enzyme activity were found during the cell cycle.
A drug-free nanozyme for mitigating oxidative stress and inflammatory bowel disease

Feng Zeng,Yahong Shi,Chunni Wu,Jianming Liang,Qixin Zhong,Karen Briley,Bin Xu,Yongzhuo Huang,Manmei Long,Cong Wang,Jian Chen,Yonghua Tang,Xinying Li,Mengda Jiang,Luting Wang,Qin Xu,Liu Yang,Peng Chen,Shengzhong Duan,Jingyuan Xie,Cong Li,Yingwei Wu

DOI: https://doi.org/10.1186/s12951-022-01319-7

IF: 10.2

2022-03-04

Journal of Nanobiotechnology

Abstract:Abstract Inflammatory bowel disease (IBD) is an incurable disease of the gastrointestinal tract with a lack of effective therapeutic strategies. The proinflammatory microenvironment plays a significant role in both amplifying and sustaining inflammation during IBD progression. Herein, biocompatible drug-free ceria nanoparticles (CeNP-PEG) with regenerable scavenging activities against multiple reactive oxygen species (ROS) were developed. CeNP-PEG exerted therapeutic effect in dextran sulfate sodium (DSS)-induced colitis murine model, evidenced by corrected the disease activity index, restrained colon length shortening, improved intestinal permeability and restored the colonic epithelium disruption. CeNP-PEG ameliorated the proinflammatory microenvironment by persistently scavenging ROS, down-regulating the levels of multiple proinflammatory cytokines, restraining the proinflammatory profile of macrophages and Th1/Th17 response. The underlying mechanism may involve restraining the co-activation of NF-κB and JAK2/STAT3 pathways. In summary, this work demonstrates an effective strategy for IBD treatment by ameliorating the self-perpetuating proinflammatory microenvironment, which offers a new avenue in the treatment of inflammation-related diseases. Graphical Abstract

biotechnology & applied microbiology,nanoscience & nanotechnology
A Programmable Oral Nanomotor Microcapsule for the Treatment of Inflammatory Bowel Disease

Jingwen Han,Jiamin Ye,Jiacheng Shi,Yueyue Fan,Xue Yuan,Ruiyan Li,Gaoli Niu,Muhammad Abubakar,Yong Kang,Xiaoyuan Ji

DOI: https://doi.org/10.1002/adfm.202413261

IF: 19

2024-11-05

Advanced Functional Materials

Abstract:An innovative oral drug delivery system using nanomotor (NM)‐loaded enteric‐coated microcapsules is developed by photocuring 3D‐printed microcapsules for targeted IBD treatment. This microcapsule effectively reduced inflammation, repaired the intestinal barrier, and modulated the gut microbiota. Given the unique anatomy and location of inflammatory bowel disease (IBD), oral pharmacological treatment is the mainstay for managing IBD because of its convenience and direct accessibility to the gastrointestinal tract. However, efficient delivery systems must be designed to navigate the harsh gastrointestinal environment during application. Here, an innovative oral drug delivery system was proposed using nanomotor (NM)‐loaded soluble microcapsules for treating IBD. MnO2‐Au‐mSiO2 NMs incorporate partially encapsulated MnO2 antennas that convert reactive oxygen species into oxygen, autonomously propelling the NMs. Astaxanthin (AST), known for its anti‐inflammatory properties, is loaded into the mesoporous silica (mSiO2) of NMs (AST@NMs). AST effectively reduces inflammation and shifts macrophages from a proinflammatory (M1) phenotype to an anti‐inflammatory (M2) phenotype. To protect the nanomotors from harsh digestive conditions and achieve intestinal‐responsive release, using photocurable 3D printing, we fabricated enteric‐coated oral microcapsules (MCs). Additionally, to prevent leakage of AST@NMs, a calcium alginate shell was cured in situ on the surface of the microcapsules (AST@NMs@MCs). In vitro and in vivo, AST@NMs@MCs effectively reduced inflammation, repaired the intestinal barrier, and modulated the gut microbiota. These findings underscore the protective effects of the microcapsules on AST@NM, highlighting their potential as a promising strategy for treating colitis.

materials science, multidisciplinary,chemistry, physical,physics, applied, condensed matter,nanoscience & nanotechnology
Astaxanthin nanoparticles ameliorate dextran sulfate sodium-induced colitis by alleviating oxidative stress, regulating intestinal flora, and protecting the intestinal barrier

Mengfan Luo,Qiaoyue Yuan,Mingzhen Liu,Xingye Song,Yingjie Xu,Tao Zhang,Xiaoqun Zeng,Zhen Wu,Daodong Pan,Yuxing Guo

DOI: https://doi.org/10.1039/d3fo03331g

IF: 6.3173

2023-10-08

Food & Function

Abstract:This study aimed to develop a novel astaxanthin nanoparticle using gum arabic (GA) and whey protein powder enriched with milk fat globule membranes (MFGM-WPI) as carriers and to investigate its effect and alleviation mechanism on colitis in mice. We demonstrated that MFGM–GA-astaxanthin could improve the bioaccessibility of astaxanthin and cope with oxidative stress more effectively in a Caco-2 cell model. In vivo studies demonstrated that MFGM–GA-astaxanthin alleviated colitis symptoms and repaired intestinal barrier function by increasing the expression of mucin 2, occludin, and zonula occludens-1. This was attributed to the alleviating effect of MFGM–GA-astaxanthin on oxidative stress. Moreover, MFGM–GA-astaxanthin restored the abnormalities of flora caused by dextran sulfate sodium, including Lactobacillus , Bacteroides , Ruminococcus , and Shigella . This study provides a basis for the therapeutic effect of astaxanthin nanoparticles on colon diseases.

biochemistry & molecular biology,food science & technology
The progression of inorganic nanoparticles and natural products for inflammatory bowel disease

Qingrong Li,Liting Lin,Cong Zhang,Hengguo Zhang,Yan Ma,Haisheng Qian,Xu-Lin Chen,Xianwen Wang

DOI: https://doi.org/10.1186/s12951-023-02246-x

IF: 10.2

2024-01-04

Journal of Nanobiotechnology

Abstract:There is a growing body of evidence indicating a close association between inflammatory bowel disease (IBD) and disrupted intestinal homeostasis. Excessive production of reactive oxygen species (ROS) and reactive nitrogen species (RNS), along with an increase in M1 proinflammatory macrophage infiltration during the activation of intestinal inflammation, plays a pivotal role in disrupting intestinal homeostasis in IBD. The overabundance of ROS/RNS can cause intestinal tissue damage and the disruption of crucial gut proteins, which ultimately compromises the integrity of the intestinal barrier. The proliferation of M1 macrophages contributes to an exaggerated immune response, further compromising the intestinal immune barrier. Currently, intestinal nanomaterials have gained widespread attention in the context of IBD due to their notable characteristics, including the ability to specifically target regions of interest, clear excess ROS/RNS, and mimic biological enzymes. In this review, we initially elucidated the gut microenvironment in IBD. Subsequently, we delineate therapeutic strategies involving two distinct types of nanomedicine, namely inorganic nanoparticles and natural product nanomaterials. Finally, we present a comprehensive overview of the promising prospects associated with the application of nanomedicine in future clinical settings for the treatment of IBD (graphic abstract).

biotechnology & applied microbiology,nanoscience & nanotechnology
ROS-responsive Nanoparticles Targeting Inflamed Colon for Synergistic Therapy of Inflammatory Bowel Disease Via Barrier Repair and Anti-Inflammation

Ding Wang,Qi Jiang,Ruoyu Shen,Lijun Peng,Wentao Zhou,Tingting Meng,Fuqiang Hu,Jianwei Wang,Hong Yuan

DOI: https://doi.org/10.1007/s12274-024-6435-6

IF: 9.9

2024-01-01

Nano Research

Abstract:The destruction of the intestinal barrier is likely to cause an increase in intestinal permeability and cause pathological damage. Numerous studies have demonstrated that intestinal barrier function plays an important role in the occurrence and development of inflammatory bowel disease (IBD). Oral administration is the most common route for intestinal diseases. In this study, a synergistic strategy is proposed for IBD management through active barrier repair combined with anti-inflammatory treatment, which can interrupt the pathological process of IBD, resulting in the significantly improved efficacy of existing treatments. Based on the specific pH values and high reactive oxygen species (ROS) levels in inflammatory sites of IBD, an orally administrated ROS-responsive drug delivery system targeting inflamed colon has been designed, and confirmed in vitro and in vivo . The antiinflammatory drug dexamethasone acetate (Dex) and the barrier function regulator LY294002 are delivered by the synthesized nanocarrier to treat IBD synergistically by inhibiting inflammation and actively repairing the intestinal barrier through tight junctions (TJs). The accumulation of nanocarriers in the inflamed colon and synergistic efficacy has been validated in mice with colitis. In brief, a drug delivery system and a therapeutic strategy for IBD are successfully developed.
ROS Scavenging and inflammation-directed polydopamine nanoparticles regulate gut immunity and flora therapy in inflammatory bowel disease

Meiyu Bao,Keyi Wang,Jingqiang Li,Yueying Li,Huanhuan Zhu,Meiling Lu,Yue Zhang,Qiangyuan Fan,Lin Han,Kesheng Wang,Dongyan Wang,Yan Gao,Bo Peng,Zunzhen Ming,Weiwei Liu

DOI: https://doi.org/10.1016/j.actbio.2023.02.026

IF: 10.633

2023-03-16

Acta Biomaterialia

Abstract:Dysfunction of the intestinal mucosal immune system and dysbiosis of the intestinal microflora can induce inflammatory bowel disease. However, drug-mediated clinical treatment remains a challenge due to its poor therapeutic efficacy and severe side effects. Herein, a ROS scavenging and inflammation-directed nanomedicine is designed and fabricated by coupling polydopamine nanoparticles with mCRAMP, an antimicrobial peptide, while wrapping macrophage membrane in the outer layer. The designed nanomedicine reduced the secretion of pro-inflammatory cytokines and elevate the expression of anti-inflammatory cytokine in vivo and in vitro inflammation models, demonstrating its significant ability of improving inflammatory responses. Importantly, the macrophage membrane encapsulated nanoparticles exhibit the obviously enhanced targeting performance in local inflamed tissues. Furthermore, the 16S rRNA sequencing of fecal microorganisms showed that probiotics increased and pathogenic bacteria were inhibited after oral delivery the nanomedicine, indicating that the designed nano platform played a significant role in optimizing intestinal microbiome. Taken together, the designed nanomedicine are not only easy to prepare and exhibit high biocompatibility, but also show the inflammatory targeting property, anti-inflammatory function and positive regulation of intestinal flora, thus providing a new idea for the intervention and treatment of colitis. Statement of significance Inflammatory bowel disease (IBD), a chronic and intractable disease, may lead to colon cancer in severe cases without effective treatment. However, clinical drugs are largely ineffective owing to insufficient therapeutic efficacies and side effects. Herein, we constructed a biomimetic polydopamine nanoparticle for oral administration to treat the IBD by modulating mucosal immune homeostasis and optimizing intestinal microorganisms. In vitro and in vivo experiments showed that the designed nanomedicine not only exhibits the anti-inflammatory function and inflammatory targeting property but also positively regulate the gut microflora. Taken together, the designed nanomedicine combined immunoregulation and intestinal microecology modulation to significantly enhance the therapeutic effect on colitis in mice, thus providing a new approach for the clinical treatment of colitis.

engineering, biomedical,materials science, biomaterials
Astaxanthin-loaded polylactic acid-glycolic acid nanoparticles ameliorate ulcerative colitis through antioxidant effects

Chunmei Li,Yu Zhou,Meng Yuan,Yawen Yang,Ruilong Song,Gang Xu,Gang Chen

DOI: https://doi.org/10.3389/fnut.2023.1267274

2023-11-09

Abstract:Introduction: Astaxanthin (AST) is a type of carotenoid with strong antioxidant effects. However, the development and use of AST are limited by its water insolubility and low bioavailability. This study aims to investigate whether AST@PLGA can inhibit UC and reveal its possible mechanism. Methods: We tested the particle size, polydispersity index, and zeta potential of AST@PLGA. Then, the in vitro release and antioxidant capacity of AST@PLGA were tested. Finally, the mouse model of colitis was established and SOD, MDA, TNF-α, IL-1β, IL-6 and P38 as well as ERK were detected from mice. Results: Particle size, polydispersity index and zeta potential of AST @PLGA were 66.78 ± 0.64 nm, 0.247 and -9.8 ± 0.53 mV, respectively, and were stable within 14 days. Then, it was observed that the AST@PLGA nanoparticles not only maintained the effect of AST but also had a sustained release effect. Experiments in mice showed that AST@PLGA effectively reduced MDA, TNF-α, IL-1β and IL-6 levels and increased SOD levels. AST@PLGA also downregulated the protein expression of P38 and ERK. The results showed the positive protective effect of AST@PLGA in inhibiting acute colitis. Discussion: AST@PLGA nanoparticles have good stability and alleviating effect in colitis, which could be functional foods in the future.
Sulfasalazine-loaded nanoparticles for efficient inflammatory bowel disease therapy via ROS-scavenging strategy

Sen Lin,Haosen Zhao,Chang Xu,Peng Zhang,Xifan Mei,Dingwen Jiang

DOI: https://doi.org/10.1016/j.matdes.2022.111465

2022-12-07

Abstract:Inflammatory bowel disease (IBD) is a life-threatening organ dysfunction amplified by complex interactions between genetic, environmental, and immune factors. Sulfasalazine (Sul), an immunosuppressant, can potentially treat autoinflammation-induced disorders; however, clinical application of Sul is hindered by its inability to be directly taken up by cells. To address this challenge, we developed Mn doped prussian blue nanozymes (MPBs) to directly deliver Sul for targeting reactive oxygen species (ROS)-enriched microenvironment. The artificial nanozyme (Sul-MPBs) exhibits reactive oxygen species (ROS)-scavenging properties against hydrogen peroxide (H 2 O 2 )-mediated mitochondrial dysfunction and possesses both catalase (CAT), superoxide dismutase (SOD), and glutathione peroxidase (GPx)-like properties in vitro . Furthermore, it significantly enhances therapeutic effects in treating dextran sulfate sodium salt (DSS)-induced IBD via alleviating ROS-mediated inflammatory responses. This study demonstrates good biocompatibility and protective properties of this artificial nanozyme, thus potentially leading to a highly innovative and translational approach to treat IBD efficiently and safely.

materials science, multidisciplinary
Oral delivery of antioxidant enzymes for effective treatment of inflammatory disease

Zhiying Zeng,Xiao He,Changying Li,Shan Lin,Hui Chen,Libing Liu,Xuli Feng

DOI: https://doi.org/10.1016/j.biomaterials.2021.120753

IF: 14

2021-04-01

Biomaterials

Abstract:Oral administration of protein is very challenging for therapeutic applications due to its instability and easy degradation in the gastrointestinal tract. Herein, we reported an approach to encapsulate native anti-inflammatory proteins in wind chimes like cyclodextrin (WCC) for efficient oral protein delivery. The amphiphilic WCC can self-assemble into nanoparticles in aqueous solution and achieve superior encapsulation of two antioxidant enzymes such as superoxide dismutase (SOD) and catalase (CAT) by simply mixing with protein solution, avoiding any extra cumbersome steps that might inactivate protein. WCC nanovehicles can effectively protect enzyme activity and enhance their intracellular delivery. SOD and CAT co-loaded WCC nanoparticles (SC/WCC) can integrate the synergistic effect of SOD and CAT for enhancing the removal of reactive oxygen species (ROS), effectively inhibit the inflammatory response by reducing the secretion of proinflammatory factors and protect cells from ROS-induced oxidative damage. In the mouse colitis model, SC/WCC administered orally was able to efficiently accumulate in the inflamed colon, significantly inhibited the expression of proinflammatory mediators and notably alleviated the symptoms related to colitis. Therefore, we believe that the strategies we described here may provide a convenient and powerful platform for the treatment of other inflammatory diseases.

engineering, biomedical,materials science, biomaterials
Orally administered titanium carbide nanosheets as anti-inflammatory therapy for colitis

Linqian Hou,Fei Gong,Bo Liu,Xiaoyuan Yang,Linfu Chen,Guangqiang Li,Yuehan Gong,Chao Liang,Nailin Yang,Xian Shen,Zhuang Liu,Liang Cheng

DOI: https://doi.org/10.7150/thno.70668

IF: 11.6

2022-01-01

Theranostics

Abstract:Rationale: Oxidative stress, resulting from excessive reactive oxygen species (ROS), plays an important role in the initiation and progression of inflammatory bowel disease (IBD). Therefore, developing novel strategies to target the disease location and treat inflammation is urgently needed. Methods: Herein, we designed and developed a novel and effective antioxidant orally-administered nanoplatform based on simulated gastric fluid (SGF)-stabilized titanium carbide MXene nanosheets (Ti3C2 NSs) with excellent biosafety and multiple ROS-scavenging abilities for IBD therapy. Results: This broad-spectrum and efficient ROS scavenging performance was mainly relied on the strong reducibility of Ti-C bound. Intracellular ROS levels confirmed that Ti3C2 NSs could efficiently eliminate excess ROS against oxidative stress-induced cell damage. Following oral administration, negatively-charged Ti3C2 NSs specifically adsorbed onto the positively-charged inflamed colon tissue via electrostatic interaction, leading to efficient therapy of dextran sulfate sodium salt (DSS)-induced colitis. The therapeutic mechanism mainly attributed to decreased ROS levels and pro-inflammatory cytokine secretion, and increased M2-phenotype macrophage infiltration and anti-inflammatory cytokine secretion, efficiently inhibiting inflammation and alleviating colitis symptoms. Due to their excellent ROS-scavenging performance, Ti3C2-based woundplast also promoted skin wound healing and functional vessel formation. Conclusions: Our study introduces redox-mediated antioxidant MXene nanoplatform as a novel type of orally administered nanoagents for treating IBD and other inflammatory diseases of the digestive tract.

medicine, research & experimental
Orally Deliverable Microalgal-Based Carrier with Selenium Nanozymes for Alleviation of Inflammatory Bowel Disease

Tao Chen,Xuesong Chi,Yangjing Li,Yanfei Li,Runan Zhao,Lihang Chen,Di Wu,Jiang-Ning Hu

DOI: https://doi.org/10.1021/acsami.4c08020

IF: 9.5

2024-09-14

ACS Applied Materials & Interfaces

Abstract:Excessive reactive oxygen species (ROS) is a hallmark of both the onset and progression of inflammatory bowel disease (IBD), where a continuous cycle of ROS and inflammation drives the progression of diseases. The design of oral antioxidant nanoenzymes for scavenging ROS has emerged as a promising strategy to intervene in IBD. However, the practical application of these nanoenzymes is limited due to their single catalytical property and significantly impacted by substantial leakage in the upper...

materials science, multidisciplinary,nanoscience & nanotechnology
Advancing Polyphenol-Based Nanomedicine for Inflammatory Bowel Disease: Challenges and Opportunities

Liucan Wang,Guoqing Chen,Yang Yang,Chao Xu,Li Zhu,Hua Yang,Min Yu

DOI: https://doi.org/10.2147/jir.s487942

IF: 4.5

2024-11-28

Journal of Inflammation Research

Abstract:Liucan Wang, &ast Guoqing Chen, &ast Yang Yang, Chao Xu, Li Zhu, Hua Yang, Min Yu Department of General Surgery, Chongqing General Hospital, Chongqing, People's Republic of China &astThese authors contributed equally to this work Correspondence: Hua Yang; Min Yu, Email ; Oxidative stress, characterized by excessive production of reactive oxygen species (ROS), is a critical factor in the progression of inflammatory bowel disease (IBD) and presents a potential therapeutic target. Anti-oxidant therapy, aimed at mitigating excessive ROS, is emerging as a cornerstone in IBD treatment. Nanomaterials with robust anti-oxidant properties offer promise by inhibiting inflammation through ROS scavenging, enhancing IBD therapeutic efficacy. Recent focus in ROS scavenging has centered on metal oxide nanoenzymes and polyphenol-based nanomaterials. The primary challenges are the catalytic efficiency of nanoenzymes and the functional integration of these nanomaterials with therapeutic agents. Polyphenols, natural plant extracts, have garnered significant interest due to their potent anti-oxidant properties and unique catechol groups that interact with biomolecules such as proteins and nucleic acids. The strong metal ion chelating ability of catechols enriches the structure and functionality of nanomaterials, improving the physicochemical properties of nanocarriers and enabling innovative designs of multifunctional drug delivery systems (DDSs). Research on polyphenol-based DDSs has expanded to include agents like epigallocatechin gallate, curcumin, resveratrol, tannic acid, and polydopamine. These nanocarriers and anti-oxidants, which incorporate polyphenols, have demonstrated potential anti-oxidant properties in novel DDSs as therapeutic agents to reduce inflammation and as essential components of drug carriers. This review focuses on the design and application of natural polyphenol-based anti-oxidant nanomaterials for IBD treatment, offering a comprehensive discussion on the use of polyphenols in DDSs and the potential challenges posed by their diverse roles in innovative drug delivery strategies, including their impact on the physical and chemical properties of DDSs. Keywords: anti-oxidant therapy, polyphenols nanomaterial, ROS scavenging, inflammation inhibition Inflammatory bowel diseases (IBD), including ulcerative colitis (UC) and Crohn's disease (CD), are chronic conditions that affect the gastrointestinal tract. These diseases are progressive and destructive, with an increasing incidence and prevalence. 1,2 Although the exact pathogenesis of IBD remains unclear, substantial evidence supports the dysregulation of inflammatory cytokines, such as IL-6, IL-10, TNF-α, and IL-1β, along with a significant increase in oxidative stress among patients. These factors are critical in triggering the development of IBD. 3–5 Current clinical therapies for IBD aim to induce remission using low molecular-weight pharmaceuticals, including amino-salicylates, corticosteroids, immunomodulators, and biologics. However, these treatments often have limited efficacy in clinical practice, facing challenges such as susceptibility to opportunistic infections, rapid clearance, limited functionality, and potential liver toxicity. 6–8 Notably, oxidative stress is known to drive the infiltration of neutrophils and macrophages into the intestinal mucosa at the site of IBD, resulting in the release of large quantities of reactive oxygen species (ROS) and inflammatory cytokines. 9 There is increasing evidence that the overproduction of ROS plays a critical role in the pathogenesis and progression of IBD. 10 Strategies that reduce inflammatory cytokines and scavenge ROS could alleviate IBD symptoms. 11–13 In this context, there is substantial potential for developing innovative therapies that effectively mitigate ROS-induced oxidative stress while exhibiting anti-inflammatory properties. Recently, nanomaterial-based interventions have emerged as promising strategies for mitigating inflammatory and oxidative damage in IBD. Among these, polyphenol-containing nanomaterials have gained extensive attention from researchers. Natural polyphenols are secondary metabolites with a polyphenolic structure, representing the predominant bioactive constituents derived from commonly consumed plants. The therapeutic potential of polyphenols in preventing or alleviating various metabolic disorders in humans has been convincingly demonstrated. 14 This naturally occurring group of substances includes a variety of compounds such as epigallocatechin gallate (EGCG), epigallocatechin (EGC), epicatechin gallate (ECG), catechin, tannic acid (TA), quercetin, gallic acid, gossypol, ellagic acid, resveratrol, caffeic acid, curcumin (CUR), rosmarinic acid (RA), a -Abstract Truncated-

immunology
Attenuation of inflammatory bowel disease by oral administration of mucoadhesive polydopamine-coated yeast β-glucan via ROS scavenging and gut microbiota regulation

Fan Yang,Yuting Su,Chi Yan,Tianfeng Chen,Peter Chi Keung Cheung

DOI: https://doi.org/10.1186/s12951-024-02434-3

IF: 10.2

2024-04-12

Journal of Nanobiotechnology

Abstract:Abstract Treatment for inflammatory bowel disease (IBD) is challenging since current anti-inflammatory and immunosuppressive therapies do not address the underlying causes of the illness, which include increased levels of reactive oxygen species (ROS) and dysbiosis of the gut commensal microbiota. Additionally, these treatments often have systemic off-target effects and adverse side effects. In this study, we have developed a prebiotic yeast β-glucan nanocomplex coated with bio-adhesive polydopamine (YBNs@PDA) to effectively prolong their retention time in the gastrointestinal (GI) tract. The oral administration of YBNs@PDA restored the epithelium barriers, reduced ROS levels, and minimized systemic drug exposure while improved therapeutic efficacy in an acute colitis mouse model. Furthermore, 16S ribosomal RNA genes sequencing demonstrated a higher richness and diversity in gut microflora composition following the treatments. In particular, YBNs@PDA markedly augmented the abundance of Lachnospiraceae NK4A136 and Bifidobacterium , both of which are probiotics with crucial roles in relieving colitis via retaining gut homeostasis. Cumulatively, these results demonstrate that the potential of YBNs@PDA as a novel drug-free, ROS-scavenging and gut microbiota regulation nanoplatform for the treatment of GI disorders.

biotechnology & applied microbiology,nanoscience & nanotechnology
Targeted no-releasing L-arginine-induced hesperetin self-assembled nanoparticles for ulcerative colitis intervention

Xuesong Chi,Tao Chen,Fengxian Luo,Runan Zhao,Yangjing Li,Shumeng Hu,Yanfei Li,Wen Jiang,LiHang Chen,Di Wu,Yinan Du,Jiangning Hu

DOI: https://doi.org/10.1016/j.actbio.2024.10.037

Abstract:Overproduction of reactive oxygen species (ROS) plays a crucial role in initiating and advancing ulcerative colitis (UC), and the persistent cycle between ROS and inflammation accelerates disease development. Therefore, developing strategies that can effectively scavenge ROS and provide targeted intervention are crucial for the management of UC. In this study, we synthesized natural carrier-free nanoparticles (HST-Arg NPs) using the Mannich reaction and π-π stacking for the intervention of UC. HST-Arg NPs are an oral formulation that exhibit good antioxidant capabilities and gastrointestinal stability. Benefiting from the negatively charged characteristics, HST-Arg NPs can specifically accumulate in positively charged inflamed regions of the colon. Furthermore, in the oxidative microenvironment of colonic inflammation, HST-Arg NPs respond to ROS by releasing nitric oxide (NO). In mice model of UC induced by dextran sulfate sodium (DSS), HST-Arg NPs significantly mitigated colonic injury by modulating oxidative stress, lowering pro-inflammatory cytokines, and repairing intestinal barrier integrity. In summary, this convenient and targeted oral nanoparticle can effectively scavenge ROS at the site of inflammation and achieve gas intervention, offering robust theoretical support for the development of subsequent oral formulations in related inflammatory interventions. STATEMENT OF SIGNIFICANCE: Nanotechnology has been extensively explored in the biomedical field, but the application of natural carrier-free nanotechnology in this area remains relatively rare. In this study, we developed a natural nanoparticle system based on hesperetin (HST), L-arginine (L-Arg), and vanillin (VA) to scavenge ROS and alleviate inflammation. In the context of ulcerative colitis (UC), the synthesized nanoparticles exhibited excellent intervention effects, effectively protecting the colon from damage. Consequently, these nanoparticles provide a promising and precise nutritional intervention strategy by addressing both oxidative stress and inflammatory pathways simultaneously, demonstrating significant potential for application.
QuEChERS Adaptability for the Analysis of Pesticide Residues in Beehive Products Seeking the Development of an Agroecosystem Sustainability Monitor.

S. Niell,Florencia Jesús,Cecilia Pérez,Yamandú Mendoza,Rosana Díaz,J. Franco,Verónica Cesio,H. Heinzen

DOI: https://doi.org/10.1021/acs.jafc.5b00795

IF: 6.1

2015-04-24

Journal of Agricultural and Food Chemistry

Abstract:Beehive products could be powerful monitors of pesticide residues originating in agroecosystems during production cycles. Their ready availability provides enough samples to perform analytical determinations, but their chemical complexity makes residue analysis a real challenge. Taking advantage of the plasticity of QuEChERS coupled to LC-MS/MS, validated methodologies were developed for bees, honey, beeswax, and pollen and applied to real samples for the simultaneous determination of 19 of the most employed pesticides in intensive cropping fields. Beehives placed in Uruguayan agroecosystems accumulated the pesticides thiacloprid, imidacloprid, methomyl, carbaryl, hexythiazox, azoxystrobin, pyraclostrobin, tebuconazole, and haloxyfop-methyl at 0.0001-0.01 mg/kg levels. The oscillations on the amount and occurrence of residue findings for specific apiaries were correlated statistically with the sampling season and the agroecosystem where the beehives were located, showing the potential of bees and bee products to record relevant information to survey the chemicals applied in their surroundings.

Determining Muscle's Force and Action in Multi‐Articular Movement

Bi-functional astaxanthin macromolecular nanocarriers to alleviate dextran sodium sulfate-induced inflammatory bowel disease

Microenvironment responsive pod-structured astaxanthin nanocarrier for ameliorating inflammatory bowel disease

Broad-Spectrum Reactive Oxygen Species Scavenging And Activated Macrophage-Targeting Microparticles Ameliorate Inflammatory Bowel Disease

Orally Administrated Inflamed Colon-Targeted Nanotherapeutics for Inflammatory Bowel Disease Treatment by Oxidative Stress Level Modulation in Colitis

Deoxyribonucleotide phosphatase from rat liver and cultured mouse fibroblasts.

A drug-free nanozyme for mitigating oxidative stress and inflammatory bowel disease

A Programmable Oral Nanomotor Microcapsule for the Treatment of Inflammatory Bowel Disease

Astaxanthin nanoparticles ameliorate dextran sulfate sodium-induced colitis by alleviating oxidative stress, regulating intestinal flora, and protecting the intestinal barrier

The progression of inorganic nanoparticles and natural products for inflammatory bowel disease

ROS-responsive Nanoparticles Targeting Inflamed Colon for Synergistic Therapy of Inflammatory Bowel Disease Via Barrier Repair and Anti-Inflammation

ROS Scavenging and inflammation-directed polydopamine nanoparticles regulate gut immunity and flora therapy in inflammatory bowel disease

Astaxanthin-loaded polylactic acid-glycolic acid nanoparticles ameliorate ulcerative colitis through antioxidant effects

Sulfasalazine-loaded nanoparticles for efficient inflammatory bowel disease therapy via ROS-scavenging strategy

Oral delivery of antioxidant enzymes for effective treatment of inflammatory disease

Orally administered titanium carbide nanosheets as anti-inflammatory therapy for colitis

Orally Deliverable Microalgal-Based Carrier with Selenium Nanozymes for Alleviation of Inflammatory Bowel Disease

Advancing Polyphenol-Based Nanomedicine for Inflammatory Bowel Disease: Challenges and Opportunities

Attenuation of inflammatory bowel disease by oral administration of mucoadhesive polydopamine-coated yeast β-glucan via ROS scavenging and gut microbiota regulation

Targeted no-releasing L-arginine-induced hesperetin self-assembled nanoparticles for ulcerative colitis intervention

QuEChERS Adaptability for the Analysis of Pesticide Residues in Beehive Products Seeking the Development of an Agroecosystem Sustainability Monitor.